You are here

Article info

Article menu
Download PDFPDF
Neuro-inflammation
Original research
Central nervous system complications associated with immune checkpoint inhibitors

Authors

  • Alberto Vogrig Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Lyon, France Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France University Claude Bernard Lyon 1, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Sergio Muñiz-Castrillo Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Lyon, France Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France University Claude Bernard Lyon 1, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Bastien Joubert Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Lyon, France Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France University Claude Bernard Lyon 1, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Geraldine Picard Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Lyon, France Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France University Claude Bernard Lyon 1, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Veronique Rogemond Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Lyon, France Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France University Claude Bernard Lyon 1, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Cécile Marchal Service de Neurologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France PubMed articlesGoogle scholar articles
  • Anne Marie Chiappa Service de Pneumologie, CH Cornouaille, Quimper, France PubMed articlesGoogle scholar articles
  • Eve Chanson Service de Neurologie, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France PubMed articlesGoogle scholar articles
  • François Skowron Service de Dermatologie, CH Valence, Valence, France PubMed articlesGoogle scholar articles
  • Amelie Leblanc Service de Neurologie, CHRU Cavale-Blanche, Brest, France PubMed articlesGoogle scholar articles
  • François Ducray Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Lyon, France Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France University Claude Bernard Lyon 1, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Jerome Honnorat Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques, Hospices Civils de Lyon, Lyon, France Synatac Team, NeuroMyoGene Institute, INSERM U1217/CNRS UMR5310, Lyon, France University Claude Bernard Lyon 1, Université de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jerome Honnorat, Centre de Référence National pour les Syndromes Neurologiques Paranéoplasiques et Encéphalites Autoimmunes, Hospices Civils de Lyon, Hôpital Neurologique, 59 Boulevard Pinel, Bron Cedex 69677, France; jerome.honnorat{at}chu-lyon.fr
View Full Text

Citation

Vogrig A, Muñiz-Castrillo S, Joubert B, et al
Central nervous system complications associated with immune checkpoint inhibitors
Journal of Neurology, Neurosurgery & Psychiatry 2020;91:772-778.

Publication history

  • Received February 17, 2020
  • Revised March 24, 2020
  • Accepted April 8, 2020
  • First published April 20, 2020.
Online issue publication 
June 18, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.